AMARA DICKERSON: Open Payments
NPI 1043722622 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,622 in 66 payments from 13 companies in 2025. Trend: 2023 $5,831 · 2024 $3,482 · 2025 $1,622
Food & beverage: $1,622
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $461 |
| ABBVIE INC. | 21 | $359 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $279 |
| Madrigal Pharmaceuticals | 2 | $111 |
| Lilly USA, LLC | 4 | $105 |
| Ardelyx, Inc. | 3 | $72 |
| QOL Medical, LLC | 3 | $51 |
| PFIZER INC. | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| GENZYME CORPORATION | 1 | $32 |
Products named: TREMFYA, RINVOQ, ENTYVIO, REZDIFFRA, OMVOH, IBSRELA, Sucraid, XELJANZ.
Industry payments across IN — which companies pay providers there.
